Tacrolimus dose individualization in de novo patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology-Reference-Cited by-同舟云学术

Tacrolimus dose individualization in de novo patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology

Published:2013-07-01 Issue:07 Volume:51 Page:606-614
ISSN:0946-1965
Container-title:Int. Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:CP

Author:

Valdivieso Naiara,Oteo Itziar,Valdivieso Andres,Lukas John C.,Leal Nerea,Gastaca Mikel,Urbina Jorge Ortiz de,Calvo Rosario,Suarez Elena

Publisher

Dustri-Verlgag Dr. Karl Feistle

Subject

Pharmacology (medical),Pharmacology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients;The Journal of Clinical Pharmacology;2022-12-29

2. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients;British Journal of Clinical Pharmacology;2022-11-06

3. Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice;Therapeutic Drug Monitoring;2021-08

4. Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review;Clinical Pharmacokinetics;2020-08-11

5. Toward a robust tool for pharmacokinetic‐based personalization of treatment with tacrolimus in solid organ transplantation: A model‐based meta‐analysis approach;British Journal of Clinical Pharmacology;2019-12